Impact of CYP2C19 Genotype-guided Approach in Antiplatelet Therapy on Platelet Reactivity Index Among Coronary Artery Disease (CAD) Patients

Clinical trial NCT06759272 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06759272
Sponsor: Nur Hafizah Annezah binti Utuh
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Arterial Disease (CAD)ACS (Acute Coronary Syndrome)SCAD

Start date: 2025-02-01
Primary completion: 2026-02-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.